Free Trial

Enzon Pharmaceuticals Q4 2023 Earnings Report

Enzon Pharmaceuticals logo
$0.19 +0.06 (+44.87%)
(As of 12/20/2024 05:55 PM ET)

Enzon Pharmaceuticals EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Enzon Pharmaceuticals Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Enzon Pharmaceuticals Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

Enzon Pharmaceuticals Earnings Headlines

This is the worst sign for the U.S. stock market in 50 years
The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"
Enzon Pharmaceuticals Inc ENZN
OKYO Pharma Limited (OK10.F)
See More Enzon Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Enzon Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enzon Pharmaceuticals and other key companies, straight to your email.

About Enzon Pharmaceuticals

Enzon Pharmaceuticals (OTCMKTS:ENZN), together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

View Enzon Pharmaceuticals Profile

More Earnings Resources from MarketBeat

Upcoming Earnings